High neutrophil to lymphocyte ratio and decreased CD69+NK cells represent a phenotype of high risk in early-stage breast cancer patients

Autor: Mandó P, Rizzo M, Roberti MP, Juliá EP, Pampena MB, Pérez de la Puente C, Loza CM, Ponce C, Nadal J, Coló FA, Mordoh J, Levy EM

Publikováno v: OncoTargets and Therapy, Vol Volume 11, Pp 2901-2910 (2018)

Pablo Mandó,1,* Manglio Rizzo,2,* María Paula Roberti,1 Estefanía Paula Juliá,1 María Betina Pampena,1 Constanza Pérez de la Puente,2 Carlos Martín Loza,2 Carolina Ponce,2 Jorge Nadal,2 Federico Andres Coló,2 José Mordoh,1–3 Estrella Marie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doajarticles::bcd17a6baf3a09b72647a390d8d911e1
https://www.dovepress.com/high-neutrophil-to-lymphocyte-ratio-and-decreased-cd69nk-cells-represe-peer-reviewed-article-OTT

1238P - Independent prognostic impact of lympho-vascular invasion in cutaneous melanoma patients with sentinel lymph node biopsy

Autor: Luca, R., Rizzo, M., Mando, P., Perez de La Puente, C., Blanco, A., Rivero, S., Lutter, G., Cappuccio, F., Amat, M., Kaplan, J., Chacon, R., Chacon, M.

Publikováno v: In Annals of Oncology September 2017 28 Supplement 5:v438-v439

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

High neutrophil to lymphocyte ratio and decreased CD69 ⁺ NK cells represent a phenotype of high risk in early-stage breast cancer patients.

Autor: Mandó P; Oncology Research Center CIO-FUCA, Buenos Aires, Argentina., Rizzo M; Alexander Fleming Institute, Buenos Aires, Argentina., Roberti MP; Oncology Research Center CIO-FUCA, Buenos Aires, Argentina., Juliá EP; Oncology Research Center CIO-FUCA, Buenos Aires, Argentina., Pampena MB; Oncology Research Center CIO-FUCA, Buenos Aires, Argentina., Pérez de la Puente C; Alexander Fleming Institute, Buenos Aires, Argentina., Loza CM; Alexander Fleming Institute, Buenos Aires, Argentina., Ponce C; Alexander Fleming Institute, Buenos Aires, Argentina., Nadal J; Alexander Fleming Institute, Buenos Aires, Argentina., Coló FA; Alexander Fleming Institute, Buenos Aires, Argentina., Mordoh J; Oncology Research Center CIO-FUCA, Buenos Aires, Argentina.; Alexander Fleming Institute, Buenos Aires, Argentina.; Biochemical Research Institute of Buenos Aires, Buenos Aires, Argentina., Levy EM; Oncology Research Center CIO-FUCA, Buenos Aires, Argentina.

Publikováno v: OncoTargets and therapy [Onco Targets Ther] 2018 May 17; Vol. 11, pp. 2901-2910. Date of Electronic Publication: 2018 May 17 (Print Publication: 2018).